Last updated: 202601120001 (y|m|d|time)
Disclaimer: Please note the default language for this website is: EN-US
EU-Disclaimer: Please note the default data sovereignty for all data collected is: USA
Welcome to Me Time COACHING!
The Me Time COACHING website, hereinafter (“Site” AND/OR “Website”) located at https://metime.one is a copyrighted work belonging to ME TIME COACHING, a BY Williams LLC Company, hereinafter (“Company” AND/OR “the Company”). Certain features of the Website (aka. “Domain” AND/OR “subdomains”) may be subject to additional guidelines, terms, agreements, or rules, which will be posted on this Website in connection with such features. All such additional terms, guidelines, agreements, and rules are incorporated by reference into this Agreement.
THIS CONFIDENTIALITY AND NON-DISCLOSURE AGREEMENT (NDA) describe and form the legally binding terms and conditions (“Agreement”) that oversee the entity or sole proprietor, hereinafter (“you” AND/OR “your” AND/OR “your representative”) usage and access to this Website or Services.
BY ACCESSING OR LOGGING INTO THE WEBSITE, YOU OR YOUR REPRESENTATIVE WILLINGLY AGREE OR ARE BEING COMPLIANT THAT THESE TERMS AND YOU REPRESENT THAT YOU OR YOUR REPRESENTATIVE HAVE THE AUTHORITY AND CAPACITY TO ENTER INTO THESE TERMS. YOU SHOULD BE AT LEAST 18 YEARS OF AGE TO ACCESS THIS WEBSITE. IF YOU DISAGREE WITH ANY OF THE PROVISIONS OF THESE TERMS, DO NOT LOG INTO AND/OR CONTINUE USAGE OF THIS WEBSITE OR SERVICES, AND DELETE YOUR BROWSER HISTORY IMMEDIATELY.
THIS CONFIDENTIALITY AND NON-DISCLOSURE AGREEMENT (this “Agreement”) become permanently effective upon the date you first access or use any service (aka. “Effective Date”) offered by the Company and continue indefinitely until you or the Company terminate it (aka. “Term”) in writing. The writing may be delivered by the Company in digital or physical form.
This Agreement extends the “Terms of Use” and/or “Terms and Conditions” located on our Terms-of-Use or Legal Page.
WITNESSETH:
WHEREAS the parties hereto desire to have discussions related to and may enter into one or more business transactions (the “Subject Matter”);
WHEREAS it is contemplated that such discussions and any business transactions entered into in connection therewith will require the disclosure by Releasor to Recipient of Confidential Information (as hereinafter defined);
WHEREAS both parties recognize the value of the Confidential Information and that it is in their mutual best interests to maintain the confidential proprietary and secret nature of the Confidential Information.
NOW THEREFORE for and in consideration of the above premises and in further consideration of the mutual covenants and promises contained herein and other good and valuable consideration the receipt adequacy and sufficiency of which are hereby acknowledged the parties hereto agree as follows:
Confidential Information shall include but not be limited to documents, records, information, and data (whether verbal, electronic, or written), drawings, models, apparatus, sketches, designs, schedules, product plans and developments, marketing plans, technical procedures, manufacturing processes, analyses, compilations, studies, software, prototypes, samples, formulas, methodologies, formulations, patent applications, know-how, experimental results, specifications, and other business information relating to Releasor’s business, assets, operations, or contracts furnished to Recipient and/or Recipient’s affiliates, officers, owners, agents, consultants, or representatives in the course of their work contemplated in this Agreement, regardless of whether such Confidential Information has been expressly designated as confidential or proprietary. Confidential Information also includes any and all compilations, work products, and other data or material prepared by or in the possession or control of the Recipient which contain, include, refer to, or otherwise reflect or are generated from any Confidential Information. Confidential Information may be provided in written, oral, electronic, or other form.
Confidential Information may be oral, visual, by demonstration, or in some other form not permanently recorded, regardless of whether such Confidential Information has been expressly designated as confidential or proprietary.
Recipient (including its affiliates, agents, and consultants) shall maintain in strict confidence for a period of five (5) years from the Effective Date and not disclose any Confidential Information it receives from Releasor to any third party or use the Confidential Information for its own or any other party’s benefit except in furtherance of its obligations to Releasor pursuant to any business transaction it may enter into with Releasor. Recipient shall use as a minimum the same degree of care to avoid disclosure or use of the Confidential Information as it employs with respect to its own confidential, proprietary, and secret information of like importance, but in any case, using no less than a reasonable degree of care. Recipient shall limit access to all Confidential Information to only those of Recipient’s personnel, agents, and representatives who “need to know” such information for carrying out Recipient’s obligations to Releasor pursuant to any business transaction it may enter into with Releasor, and the Confidential Information will be used only for carrying out Recipient’s obligations to Releasor pursuant to any business transaction it may enter into with Releasor. Recipient shall ensure that its affiliates, officers, directors, owners, agents, consultants, and representatives who are given access to the Confidential Information by or on behalf of Recipient shall be bound by and shall comply with the terms of this Agreement.
Information shall not be deemed Confidential Information and Recipient shall have no obligation of confidentiality or restriction against use with respect to any information which:
In the event Recipient is requested or required by a government or court order or similar process to disclose any Confidential Information supplied to it by Releasor, Recipient shall provide Releasor with prompt notice of such request so that Releasor may seek an appropriate protective order and/or waive Recipient’s compliance with the provisions of this Agreement.
Recipient shall reimburse, indemnify, and hold harmless Releasor and its affiliates, owners, officers, directors, agents, and representatives from any damage, loss, penalty, cost, or expense incurred by Releasor as a result of or in connection with the use or disclosure of the Confidential Information contrary to the terms of this Agreement by Recipient or its affiliates, officers, directors, owners, consultants, agents, or representatives or any others to whom such Confidential Information has been disclosed by any such persons or entities. The term “affiliates” as used in this Agreement shall mean any persons, corporations, partnerships, limited liability companies, or other business entities which directly or indirectly control, are controlled by, or are in common control with such party to this Agreement. As used herein the term “control” shall mean possession, directly or indirectly, of power to direct or cause the direction of management or policies (whether through ownership of securities, by contract, or otherwise).
Recipient shall not directly or indirectly make any public comment, statement, or communication with respect to or otherwise disclose or permit the disclosure to any third party of any Confidential Information or of any matter relating to the Subject Matter or purpose or any transactions contemplated by the parties in connection therewith without the prior written consent of Releasor.
Recipient shall notify Releasor immediately upon discovery of any unauthorized use or disclosure of Confidential Information or any other breach of this Agreement by Recipient or any third party and will cooperate with Releasor in every reasonable way to help regain possession of the Confidential Information and prevent its further unauthorized use or disclosure.
All Confidential Information disclosed to Recipient shall be and remain the property of Releasor. Upon Releasor’s written request, Recipient shall promptly return all Confidential Information (including all originals, copies, reproductions, and summaries of such Confidential Information) or certify its destruction in writing and keep the same confidential and secret in accordance with this Agreement.
Nothing contained in this Agreement shall be construed as granting or conferring to Recipient any rights or license or otherwise either expressly or by implication in or to any Confidential Information disclosed by Releasor to Recipient as a result of this Agreement, including without limitation rights or license under any present or future patent, patent application, copyright, trademark, service mark, trade secret, or other proprietary information owned, licensed, or controlled by Releasor.
Recipient’s obligations of non-disclosure pursuant to the terms of this Agreement shall survive until all Confidential Information has been returned to Releasor or the destruction thereof has been certified to Releasor in writing.
This Agreement shall not be construed as a joint venture, pooling arrangement, partnership, teaming effort, or agency arrangement. The Parties shall be entered into a Releasor-Recipient relationship and any other financial arrangements shall be written in another document.
Neither party waives any rights in invention or development lawfully possessed by it at the time of signing this Agreement. In addition, this Agreement does not imply any waiver of any rights or action under the patent, trademark, copyright, trade secret, unfair competition, fair trade, or related laws. Failure to enforce any provision of this Agreement shall not constitute a waiver of any term hereof.
This Agreement shall be binding upon Recipient and its subsidiaries, successors, assigns, legal representatives, and all corporations controlling Recipient or controlled by Recipient and shall inure to the benefit of Releasor and its subsidiaries, successors, assigns, legal representatives, and all corporations controlling Releasor or controlled by Releasor.
Recipient understands and agrees that any use or dissemination of Confidential Information in violation of this Agreement will cause Releasor irreparable harm and that monetary damages may not be a sufficient remedy for unauthorized use or disclosure of Confidential Information and that Releasor may be left with no adequate remedy at law; therefore Releasor shall be entitled, without waiving any other rights or remedies, to such injunctive or equitable relief as may be deemed proper by a court of competent jurisdiction. Such remedies shall not be deemed to be the exclusive remedy for any breach of this Agreement but shall be in addition to all other remedies available at law or in equity.
This Agreement shall be governed by, construed, and enforced in accordance with the laws of the State of Florida without regard to its conflicts of laws provisions.
This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, understandings, negotiations, and discussions, whether oral or written, between the parties. Any amendments, modifications, or supplements to this Agreement must be in writing and signed by authorized representatives of both parties.
If any provision of this Agreement is held to be invalid or unenforceable by a court of competent jurisdiction, the remaining provisions will continue in full force and effect.
Recipient may not assign this Agreement or any interest herein without Releasor’s prior written consent.
This Agreement may be executed in counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument.
This Agreement may be subject to change from time to time. The revised Agreement will be published on this page. We will not reduce your rights under this Agreement without your explicit consent. Please regularly check this Agreement to ensure you are aware of the latest updates.
If you have any questions about this Confidentiality and Non-Disclosure Agreement (NDA), please contact us:
Contact Information
7901 4th St N, SUITE 4000,
ATTN: BY WILLIAMS LLC, DPT: MTC
St. Petersburg, FL 33702
Email: eno.emitem@troppus
